John Libbey Eurotext

Epileptic Disorders

The Educational Journal of the

Efficacy and safety of lacosamide as an adjunctive therapy for refractory focal epilepsy in paediatric patients: a retrospective single-centre study Volume 17, numéro 4, December 2015

Illustrations

  • Figure 1

Tableaux

Auteurs
1 CHU Sainte-Justine Research Center
2 Division of Neurology, Department of Neurosciences and Paediatrics, CHU Sainte Justine, University of Montreal, Montreal, Quebec, Canada
* Correspondence: Ala Birca Division of Neurology, Department of Neurosciences and Paediatrics, CHU Sainte Justine, University of Montreal, 3175 Côte Ste-Catherine, Montreal, QC, H3T 1C5, Canada
  • Mots-clés : lacosamide, antiepileptic drug, refractory epilepsy, treatment, pediatric patients
  • DOI : 10.1684/epd.2015.0782
  • Page(s) : 436-43
  • Année de parution : 2015

Aim

Lacosamide is an antiepileptic drug approved for the treatment of focal epilepsy in adult patients. The aim of this observational study was to review our centre's experience with lacosamide and to characterize its effectiveness and tolerability as an adjunctive antiepileptic drug in a retrospective cohort of children with refractory focal epilepsy.